Skip to content

Clinical trials

Completed Phase 2 Venous Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Phase 2 Status: Completed Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20044
20052
20064
20072
20081
20092
20101
20111
20123
20131
20143
20153
20175
20182
20191
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Boehringer Ingelheim6
University of Utah4
Regeneron Pharmaceuticals3
Daiichi Sankyo2
Daiichi Sankyo Co., Ltd.2
GlaxoSmithKline2
Hamilton Health Sciences Corporation2
Ottawa Hospital Research Institute2
Hanyang University Seoul Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism43
Venous Thrombosis14
Pulmonary Embolism6
Atrial Fibrillation4
Thromboembolism4
Embolism and Thrombosis2
Hemorrhage2
Neoplasms2
Thrombosis2
Embolism1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.